These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30632809)

  • 1. Cause of death analysis and temporal trends in survival after liver transplantation for transthyretin familial amyloid polyneuropathy.
    Algalarrondo V; Antonini T; Théaudin M; Chemla D; Benmalek A; Castaing D; Cauquil C; Rouzet F; Mika D; Duong E; Dinanian S; Eliahou L; Le Guludec D; Samuel D; Adams D; Slama MS
    Amyloid; 2018 Dec; 25(4):253-260. PubMed ID: 30632809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver Transplantation.
    Algalarrondo V; Antonini T; Théaudin M; Chemla D; Benmalek A; Lacroix C; Castaing D; Cauquil C; Dinanian S; Eliahou L; Samuel D; Adams D; Le Guludec D; Slama MS; Rouzet F
    JACC Cardiovasc Imaging; 2016 Dec; 9(12):1432-1441. PubMed ID: 27838303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
    Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified body mass index and time interval between diagnosis and operation affect survival after liver transplantation for hereditary amyloidosis: a single-center analysis.
    Franz C; Hoffmann K; Hinz U; Singer R; Hund E; Gotthardt DN; Ganten T; Kristen AV; Hegenbart U; Schönland S; Hinderhofer K; Büchler MW; Schemmer P
    Clin Transplant; 2013; 27 Suppl 25():40-8. PubMed ID: 23909501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation in transthyretin amyloidosis: issues and challenges.
    Carvalho A; Rocha A; Lobato L
    Liver Transpl; 2015 Mar; 21(3):282-92. PubMed ID: 25482846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manifestations of transthyretin-related familial amyloidotic polyneuropathy: long-term follow-up of Japanese patients after liver transplantation.
    Ohya Y; Okamoto S; Tasaki M; Ueda M; Jono H; Obayashi K; Takeda K; Okajima H; Asonuma K; Hara R; Tanihara H; Ando Y; Inomata Y
    Surg Today; 2011 Sep; 41(9):1211-8. PubMed ID: 21874417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
    Ericzon BG; Wilczek HE; Larsson M; Wijayatunga P; Stangou A; Pena JR; Furtado E; Barroso E; Daniel J; Samuel D; Adam R; Karam V; Poterucha J; Lewis D; Ferraz-Neto BH; Cruz MW; Munar-Ques M; Fabregat J; Ikeda S; Ando Y; Heaton N; Otto G; Suhr O
    Transplantation; 2015 Sep; 99(9):1847-54. PubMed ID: 26308415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation.
    Banerjee D; Roeker LE; Grogan M; Swiecicki P; Poterucha J; Heimbach J; Zeldenrust S; Gertz M; Edwards B; Daly R; Klarich KW; Dispenzieri A
    Prog Transplant; 2017 Sep; 27(3):246-250. PubMed ID: 29187090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive risk stratification of patients with transthyretin amyloidosis.
    Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
    JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy.
    Coutinho MC; Cortez-Dias N; Cantinho G; Conceição I; Oliveira A; Bordalo e Sá A; Gonçalves S; Almeida AG; de Carvalho M; Diogo AN
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):627-36. PubMed ID: 23833285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort study.
    Vollmar J; Schmid JC; Hoppe-Lotichius M; Barreiros AP; Azizi M; Emrich T; Geber C; Schad A; Weyer V; Otto G; Heise M; Mittler J; Birklein F; Lang H; Galle PR; Zimmermann T
    Transpl Int; 2018 Nov; 31(11):1207-1215. PubMed ID: 30091268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation in transthyretin amyloidosis: Characteristics and management related to kidney disease.
    Rocha A; Lobato L
    Transplant Rev (Orlando); 2017 Apr; 31(2):115-120. PubMed ID: 27671053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis.
    Wixner J; Sundström T; Karling P; Anan I; Suhr OB
    BMC Gastroenterol; 2015 Apr; 15():51. PubMed ID: 25908211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation.
    Matsushima M; Yabe I; Tsuda M; Sakakibara M; Shimamura T; Sasaki H
    Intern Med; 2017 Dec; 56(23):3231-3235. PubMed ID: 28943540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transthyretin-related hereditary amyloidosis].
    Vionnet J; Pascual M; Kuntzer T; Yerly P; Moradpour D
    Rev Med Suisse; 2016 Aug; 12(528):1434-1440. PubMed ID: 28675284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of liver transplantation for familial amyloid polyneuropathy type I in Brazil.
    Bittencourt PL; Couto CA; Farias AQ; Marchiori P; Bosco Massarollo PC; Mies S
    Liver Transpl; 2002 Jan; 8(1):34-9. PubMed ID: 11799483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy.
    Nelson LM; Penninga L; Villadsen GE; Mølgaard H; Eiskjaer H; Hillingsø JG; Rasmussen A
    Clin Transplant; 2015 Dec; 29(12):1098-104. PubMed ID: 26361241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of liver transplantation for familial amyloidotic polyneuropathy.
    Sharma P; Perri RE; Sirven JE; Zeldenrust SR; Brandhagen DJ; Rosen CB; Douglas DD; Mulligan DC; Rakela J; Wiesner RH; Balan V
    Liver Transpl; 2003 Dec; 9(12):1273-80. PubMed ID: 14625827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between tafamidis and liver transplantation as first-line therapy for hereditary transthyretin amyloidosis.
    Socie P; Benmalek A; Cauquil C; Piekarski E; Kounis I; Eliahou L; Rousseau A; Rouzet F; Echaniz-Laguna A; Samuel D; Adams D; Slama MS; Algalarrondo V
    Amyloid; 2023 Sep; 30(3):303-312. PubMed ID: 36795029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of long-term survival after liver transplantation for familial transthyretin amyloidosis.
    Algalarrondo V; Antonini T; Théaudin M; Ducot B; Lozeron P; Chemla D; Benmalek A; Lacroix C; Azoulay D; Castaing D; Cauquil C; Rouzet F; Dinanian S; Eliahou L; Le Guludec D; Samuel D; Slama MS; Adams D
    J Am Coll Cardiol; 2015 Nov; 66(19):2154-2156. PubMed ID: 26541929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.